Compare ACOG & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | PDEX |
|---|---|---|
| Founded | 2000 | 1978 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.4M | 106.5M |
| IPO Year | N/A | N/A |
| Metric | ACOG | PDEX |
|---|---|---|
| Price | $4.88 | $39.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $18.00 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 74.8K | 25.5K |
| Earning Date | 03-30-2026 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 76.21 |
| EPS | N/A | ★ 3.41 |
| Revenue | $7,427,199.00 | ★ $72,101,000.00 |
| Revenue This Year | N/A | $7.22 |
| Revenue Next Year | $132.35 | N/A |
| P/E Ratio | ★ N/A | $11.59 |
| Revenue Growth | N/A | ★ 18.19 |
| 52 Week Low | $3.75 | $23.47 |
| 52 Week High | $11.54 | $70.26 |
| Indicator | ACOG | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 51.12 |
| Support Level | $4.75 | $37.07 |
| Resistance Level | $5.99 | $40.50 |
| Average True Range (ATR) | 0.58 | 1.78 |
| MACD | 0.04 | -0.14 |
| Stochastic Oscillator | 63.36 | 55.38 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.